Practical Approaches to Overactive Bladder: From Diagnosis to Goal Attainment

Release Date: Monday, September 12, 2022
Expiration Date: Tuesday, September 12, 2023

EDUCATIONAL OVERVIEW
Overactive bladder (OAB) is a chronic, debilitating condition that impacts approximately 16% of the population in the United States. OAB is more prevalent in older adults, with one estimate of 40.4% in elderly men and 46.9% in elderly women. Though OAB is a common problem, relatively few individuals with symptoms of OAB seek medical care and even fewer receive care. For this reason, OAB is often termed the “hidden condition” as many who suffer from the condition consider OAB a normal part of aging and fail to report it to their physician. Left untreated, OAB can significantly impact a patient’s quality of life, including physical, psychological, social, occupational, and sexual aspects.

Clinicians in the primary care setting are well positioned to improve the outcomes of patients with OAB symptoms by early detection and effective utilization of current therapeutic approaches. PCPs must communicate with patients initially about recognizing OAB symptoms, and then by developing realistic patient-specific treatment goals that meet patient expectations. Through routine evaluation of treatment effectiveness and tolerability while making necessary adjustments, PCPs can make a significant impact in improving the overall well-being of patients with OAB.

LEARNING OBJECTIVES
Upon completing this activity, participants will be able to:

Utilize communication and diagnostic techniques for early detection and diagnosis of overactive bladder (OAB) among at-risk patients
Review patient factors to consider when selecting between anticholinergics and beta-3 adrenoceptor agonists for OAB treatment
Select appropriate OAB pharmacologic therapy based on efficacy data, safety profile, and patient factors and preferences

TARGET AUDIENCE
This educational activity is designed to address the practice needs of primary care providers, including primary care physicians, osteopathic physicians, physician assistants, nurse practitioners, and allied healthcare professionals, who are at the forefront of caring for adult patients who may be suffering from OAB.

FACULTY

	Diane K. Newman, DNP FAAN BCB-PMD Adjunct Professor of Urology in Surgery Research Investigator Senior Perelman School of Medicine University of Pennsylvania Philadelphia, PA

EDUCATIONAL FORMAT

This online presentation builds competence, confidence, and skills in the understanding of how to utilize patient-provider communication and therapeutic approaches to improve OAB outcomes and reduce disease burden. The faculty presentation emphasizes the importance of adequate communication with patients with OAB at various stages of patient care, including starting a dialog about OAB symptoms, understanding patient expectations with treatment, and setting realistic patient-centered treatment goals. Several case vignettes illustrate OAB management at the various stages of disease and emphasize a treat-to-target approach that involves regular follow-up to evaluate patient outcomes and tolerability followed by treatment adjustment when needed. The emphasis is placed on the special considerations in the use of OAB medications in at-risk populations, such as the elderly.

The presentation covers the following topics:

Identifying the at-risk population
Initiating the conversation about OAB
Making the differential diagnosis
AUA/SUFU guideline recommendations
Implementing a treat-to-target approach
Evaluating patient outcomes and expectations
Managing adverse effects

Accreditation and Credit Designation Statement

Physicians

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education through the joint providership of Center for Independent Healthcare Education (Center) and Vemco MedEd. Center is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

Center designates this Enduring material for a maximum of 0.75 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Physician Assistants
AAPA accepts AMA PRA Category 1 Credit™ for the PRA from organizations accredited by ACCME.

Nurse Practitioners
Nurse Practitioners will receive certificate of AMA PRA Category 1 Credit™ as this is an ACCME accredited program and its accreditation is recognized by Nurse Practitioner boards.

For questions regarding the accreditation of this activity, please contact us at info@jointsponsor.com

Method of Participation and Instruction for Credit

Review the entire CME information including target audience, learning objectives, and disclosures.
Review the activity in its entirety.
Complete the Online Post Test, Evaluation, and Credit Application form
Please note that to receive credit you must achieve a score of at least 80%.
Certificate of Credit will be emailed to you within 4 weeks.

Disclosure of Financial Relationships with Ineligible Companies
Center for Independent Healthcare Education and Vemco MedEd fully comply with the Standards for Integrity and Independence in Accredited Continuing Education in development of CME/CPE activities. We require the full disclosure of financial relationships with ineligible companies from all individuals in a position to influence the content of a certified activity, in any amount occurring within the past 24 months. All relevant financial relationship is identified by the provider and mitigated to prevent inserting commercial bias into content. All identified relevant financial relationships are disclosed to the learners prior to the activity. The faculty is further required to disclose discussion of off-label uses in their presentations.

Disclosures
Diane K. Newman, DNP reported the following relevant financial relationships with ineligible companies:
Advisory Board: Urovant Sciences

All relevant financial relationships have been mitigated.
Dr. Newman does not discuss off-label uses of any products.

No (other) speakers, authors, planners or content reviewers have any relevant financial relationships to disclose.

Content review confirmed that the content was developed in a fair, balanced manner free from commercial bias. Disclosure of a relationship is not intended to suggest or condone commercial bias in any presentation, but it is made to provide participants with information that might be of potential importance to their evaluation of a presentation.

Fee
There is no fee to participate in this activity.

Hardware/Software Requirements
Microsoft Internet Explorer, Mozilla Firefox, Apple Safari or Google Chrome with the QuickTime Plug-in Note: Please disable any “pop-up blocker” features.

System Check
Please e-mail any questions or concerns to info@vemcomeded.com.

Privacy Policy
http://www.vemcomeded.com/privacy.asp

Joint Providership
This activity is jointly provided by Center for Independent Healthcare Education and Vemco MedEd.

Commercial Support
This activity is supported by an educational grant from Urovant Sciences, Inc.

START ACTIVITY
By clicking below, I acknowledge that I have read the entire CME information.